Dr. Ian Krop

Biography

Ian Krop, MD, PhD, is a professor of internal medicine specializing in medical oncology at Yale School of Medicine. He has held leadership roles at Yale Cancer Center, including being the Associate Director for Clinical Research and the Chief Clinical Research Officer. Krop's research extensively focuses on the treatment of HER2-positive breast cancer, investigating innovative therapies, genomic tools, and patient-reported outcomes. His participation in various clinical trials aims to explore the effectiveness of neoadjuvant therapies in cancer treatment and manage the spread of cancer to the brain. His research has been instrumental in improving the understanding of resistance therapies and identifying potential tumor suppressors in HER2-positive breast cancer. Dr. Krop and his research team have received significant funding from the National Cancer Institute, the Susan G. Komen Breast Cancer Foundation, and the Breast Cancer Research Foundation, influencing patient care and medical education. He also serves as a member of several committees, including the NCI Breast Cancer Steering Committee, and is actively involved in Data Safety Monitoring Boards for multiple phase III trials.

Research Interests